These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35797353)

  • 1. The global mRNA vaccine patent landscape.
    Li M; Ren J; Si X; Sun Z; Wang P; Zhang X; Liu K; Wei B
    Hum Vaccin Immunother; 2022 Nov; 18(6):2095837. PubMed ID: 35797353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stem cell patent landscape as relevant to cancer vaccines.
    Wang SJ
    Hum Vaccin; 2011 Oct; 7(10):1100-8. PubMed ID: 21957493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.
    Musyuni P; Aggarwal G; Nagpal M; Goyal RK
    Curr Pharm Des; 2021; 27(3):423-439. PubMed ID: 32693757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of technological developments in lipid nanoparticle application for mRNA vaccination.
    Yeh TF; Lin C; Sung HC
    Hum Vaccin Immunother; 2023 Aug; 19(2):2256040. PubMed ID: 37705354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global patent landscape of programmed cell death 1: implications of the rapid expansion.
    Kong X; Zhang Q; Lai Y; Hu H; Chen X; Hu Y
    Expert Opin Ther Pat; 2018 Jan; 28(1):69-80. PubMed ID: 28891360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging CAR T cell therapies: clinical landscape and patent technological routes.
    Picanco-Castro V; Gonçalves Pereira C; Swiech K; Ribeiro Malmegrim KC; Tadeu Covas D; Silveira Porto G
    Hum Vaccin Immunother; 2020 Jun; 16(6):1424-1433. PubMed ID: 31702480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What, Where, When and How of COVID-19 Patents Landscape: A Bibliometrics Review.
    Liu K; Zhang X; Hu Y; Chen W; Kong X; Yao P; Cong J; Zuo H; Wang J; Li X; Wei B
    Front Med (Lausanne); 2022; 9():925369. PubMed ID: 35847804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Economic Theory of Patent Protection and Pandemic Influenza Vaccines: Do Patents Really Incentivize Innovation in the Field?
    Eccleston-Turner M
    Am J Law Med; 2016 May; 42(2-3):572-597. PubMed ID: 29086638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic-cell-based technology landscape: Insights from patents and citation networks.
    Kong X; Hu Y; Cai Z; Yang F; Zhang Q
    Hum Vaccin Immunother; 2015; 11(3):682-8. PubMed ID: 25714961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global research on artemisinin and its derivatives: Perspectives from patents.
    Liu K; Zuo H; Li G; Yu H; Hu Y
    Pharmacol Res; 2020 Sep; 159():105048. PubMed ID: 32590098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patent trend and competitive analysis of cancer immunotherapy in the United States.
    Pan CL; Chen FC
    Hum Vaccin Immunother; 2017 Nov; 13(11):2583-2593. PubMed ID: 28881159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Innovation Trends for Plant-Based Vaccines Production: A Patent Analysis.
    Frisio DG; Ventura V
    Plants (Basel); 2021 Nov; 10(12):. PubMed ID: 34961028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress on mRNA vaccine for the prevention of major infectious diseases in humans and animals].
    Gao JQ; Zhao XJ; Hua JL
    Sheng Li Xue Bao; 2023 Oct; 75(5):647-658. PubMed ID: 37909136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The geographical dynamics of global R&D collaboration networks in robotics: Evidence from co-patenting activities across urban areas worldwide.
    Scherngell T; Schwegmann K; Zahradnik G
    PLoS One; 2023; 18(4):e0281353. PubMed ID: 37053220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patent data mining: a tool for accelerating HIV vaccine innovation.
    Clark K; Cavicchi J; Jensen K; Fitzgerald R; Bennett A; Kowalski SP
    Vaccine; 2011 May; 29(24):4086-93. PubMed ID: 21496469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conotoxin Patenting Trends in Academia and Industry.
    Sanchez-Campos N; Bernaldez-Sarabia J; Licea-Navarro AF
    Mar Drugs; 2022 Aug; 20(8):. PubMed ID: 36005534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patents as a Driver of the Unprecedented Biomedical Response to COVID-19.
    Mossoff A; Adalja A
    Inquiry; 2022; 59():469580221124819. PubMed ID: 36129280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Current Landscape of mRNA Vaccines Against Viruses and Cancer-A Mini Review.
    Ladak RJ; He AJ; Huang YH; Ding Y
    Front Immunol; 2022; 13():885371. PubMed ID: 35603213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy.
    Duan LJ; Wang Q; Zhang C; Yang DX; Zhang XY
    Front Immunol; 2022; 13():923647. PubMed ID: 35711457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.